Clinical trial
A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is…
NCT00246584 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00246584 |
|---|---|
| Title | A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US) |
| Official title | Long-Term Treatment, Multicenter, Open-Label Study With SPP100 in Patients With Essential Hypertension |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Hypertension |
| Intervention type | Drug |
| Interventions | SPP100 |
| Enrollment | 300 |
| Start date | Oct 1, 2004 |
| First posted | Oct 31, 2005 |
| Last update posted | Jul 28, 2006 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: